文献速递外周动脉疾病

COVID-19大流行对专职血管急诊门诊的影响

The Impact of the COVID-19 Pandemic on a Dedicated Vascular Emergency Clinic.
PubMed 文献 · Ann Vasc Surg · 2023-04-05

该回顾性研究评估了2020年3月至2021年4月期间专职血管急诊门诊(VEC)对COVID-19大流行的韧性,共纳入791例患者、1084次评估,其中322例(40.7%)诊断为慢性肢体威胁性缺血(CLTI)。CLTI患者从转诊至评估的中位时间为3天,非住院CLTI患者从评估至干预的中位时间为8天、从转诊至干预的中位时间为11天,12个月随访时大截肢率为10.9%、死亡率为25.8%,结论认为VEC模式对COVID-19大流行表现出强韧性并维持了快速治疗时间线。

要点

  • VEC提供「一站式」开放准入,医疗专业人员或患者怀疑CLTI即可直接就诊。
  • 322例(40.7%)诊断为CLTI,12个月随访大截肢率10.9%、死亡率25.8%。
  • 非住院CLTI患者转诊至评估中位3天,评估至干预中位8天,转诊至干预中位11天。

核心结论

  • VEC模式对COVID-19大流行表现出强韧性,并为CLTI患者维持了快速的治疗时间线。

研究设计与样本

  • 回顾性审查2020年3月至2021年4月期间在本中心VEC接受下肢病变评估的所有患者的前瞻性维护数据库,并与国家和地方区域政府COVID-19数据交叉参照。
  • 共791例患者接受了1084次评估(男性484例,61%;年龄72.5±标准差12.2岁;白人英国人645例,81.7%)。
  • 对CLTI个体进一步分析以确定外周动脉疾病质量改进框架(PAD-QIF)的依从性。

主要发现

  • 322例患者诊断为CLTI(40.7%)。
  • 188例(58.6%)接受了首次血运重建策略:血管内128例(39.8%)、杂交41例(12.7%)、开放手术19例(5.9%)、保守治疗134例(41.6%)。
  • 12个月随访时大截肢率为10.9%(n=35),死亡率为25.8%(n=83)。
  • 转诊至评估的中位时间为3天(四分位距:1-5)。
  • 非住院CLTI患者评估至干预的中位时间为8天(四分位距:6-15),转诊至干预的中位时间为11天(11-18)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vascular Emergency Clinics (VEC) improve patient outcomes in chronic limb-threatening ischemia (CLTI). They provide a "1 stop" open access policy, whereby "suspicion of CLTI" by a healthcare professional or patient leads to a direct review. We assessed the resilience of the outpatient VEC model to the first year of the coronavirus disease (COVID-19) pandemic. METHODS: A retrospective review of a prospectively maintained database of all patients assessed in our VEC for lower limb pathologies between March 2020 and April 2021 was performed. This was cross-referenced to national and loco-regional Governmental COVID-19 data. Individuals with CLTI were further analysed to determine Peripheral Arterial Disease-Quality Improvement Framework compliance. RESULTS: Seven hundred and ninety one patients attended for 1,084 assessments (Male n = 484, 61%; Age 72.5 ± standard deviation 12.2 years; White British n = 645, 81.7%). In total, 322 patients were diagnosed with CLTI (40.7%). A total of 188 individuals (58.6%) underwent a first revascularization strategy (Endovascular n = 128, 39.8%; Hybrid n = 41, 12.7%; Open surgery n = 19, 5.9%; Conservative n = 134, 41.6%). Major lower limb amputation rate was 10.9% (n = 35) and mortality rate was 25.8% (n = 83) at 12 months of follow-up. Median referral to assessment time was 3 days (interquartile range: 1-5). For the nonadmitted patient with CLTI, the median assessment to intervention was 8 days (interquartile range: 6-15) and median referral to intervention time of 11 days (11-18). CONCLUSIONS: The VEC model has demonstrated strong resilience to the COVID-19 pandemic with rapid treatment timelines maintained for patients with CLTI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Messeder SJ, Black I, Nickinson ATO, et al. The Impact of the COVID-19 Pandemic on a Dedicated Vascular Emergency Clinic. Ann Vasc Surg. 2023. PMID: 37023916. doi:10.1016/j.avsg.2023.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。